Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Novel therapeutic option for orbital atypical lymphoid hyperplasia.

Talaulikar D, Tridgell D, Leong D, Dahlstrom JE, Cherian M, Prosser I, Sunderland K.

Clin Exp Ophthalmol. 2010 Dec;38(9):892-4. doi: 10.1111/j.1442-9071.2010.02378.x.

PMID:
20662847
2.

Long-term management of orbital and systemic reactive lymphoid hyperplasia with rituximab.

Chen A, Hwang TN, Phan LT, McCulley TJ, Yoon MK.

Middle East Afr J Ophthalmol. 2012 Oct;19(4):432-5. doi: 10.4103/0974-9233.102770.

4.

Treatment of benign orbital pseudolymphomas with the monoclonal anti-CD20 antibody rituximab.

Witzig TE, Inwards DJ, Habermann TM, Dogan A, Kurtin PJ, Gross JB Jr, Ananthamurthy A, Ristow KM, Garity JA.

Mayo Clin Proc. 2007 Jun;82(6):692-9.

PMID:
17550749
5.

Radiotherapy of lymphoid diseases of the orbit.

Austin-Seymour MM, Donaldson SS, Egbert PR, McDougall IR, Kriss JP.

Int J Radiat Oncol Biol Phys. 1985 Feb;11(2):371-9.

PMID:
3918966
6.

Radiotherapy of lymphoproliferative diseases of the orbit. Surveillance of 65 cases.

Keleti D, Flickinger JC, Hobson SR, Mittal BB.

Am J Clin Oncol. 1992 Oct;15(5):422-7.

PMID:
1524043
7.

Tertiary lymphoid neogenesis is a component of pulmonary lymphoid hyperplasia in patients with common variable immunodeficiency.

Maglione PJ, Ko HM, Beasley MB, Strauchen JA, Cunningham-Rundles C.

J Allergy Clin Immunol. 2014 Feb;133(2):535-42. doi: 10.1016/j.jaci.2013.08.022. Epub 2013 Oct 13.

8.

Orbital presentation of posttransplantation lymphoproliferative disorder: a small case series.

Douglas RS, Goldstein SM, Katowitz JA, Gausas RE, Ibarra MS, Tsai D, Sharma A, Nichols C.

Ophthalmology. 2002 Dec;109(12):2351-5.

PMID:
12466183
9.

Orbital lymphoproliferative and inflammatory lesions.

White V, Rootman J, Quenville N, Worth A, Robertson W.

Can J Ophthalmol. 1987 Dec;22(7):362-73.

PMID:
3325158
10.

Treatment of benign lymphoid hyperplasia of the orbit with rituximab.

Ho HH, Savar A, Samaniego F, Manning J, Kasyan A, Pro B, Esmaeli B.

Ophthal Plast Reconstr Surg. 2010 Jan-Feb;26(1):11-3. doi: 10.1097/IOP.0b013e3181b8e056.

PMID:
20090476
11.

Prognosis of orbital lymphoid hyperplasia.

Polito E, Leccisotti A.

Graefes Arch Clin Exp Ophthalmol. 1996 Mar;234(3):150-4.

PMID:
8720713
12.

Treatment of cutaneous lymphoid hyperplasia with the monoclonal anti-CD20 antibody rituximab.

Martin SJ, Duvic M.

Clin Lymphoma Myeloma Leuk. 2011 Jun;11(3):286-8. doi: 10.1016/j.clml.2011.03.017. Epub 2011 Apr 20.

PMID:
21658657
13.

Adult orbital xanthogranuloma successfully treated with rituximab.

Satchi K, McNab AA, Godfrey T, Prince HM.

Ophthalmology. 2014 Aug;121(8):1664-5.e1-3. doi: 10.1016/j.ophtha.2014.02.024. Epub 2014 May 6. No abstract available.

PMID:
24811966
14.

Usefulness and limitations of rituximab in managing patients with lymphoproliferative disorder after heart transplantation.

Senechal M, Demers S, Cantin B, Bourgault C, Leblanc MH, Morin J, Couture C.

Exp Clin Transplant. 2012 Oct;10(5):513-8. doi: 10.6002/ect.2012.0012. Epub 2012 Jun 29.

15.

Polyclonal orbital and systemic infiltrates.

Rootman J, Patel S, Jewell L.

Ophthalmology. 1984 Sep;91(9):1112-7.

PMID:
6493720
16.

Lymphoid proliferations in the orbit: malignant or benign?

van der Gaag R, Koornneef L, van Heerde P, Vroom TM, Pegels JH, Feltkamp CA, Peeters HJ, Gillissen JP, Bleeker GM, Feltkamp TE.

Br J Ophthalmol. 1984 Dec;68(12):892-900.

17.
18.

Immunohistologic diagnosis of orbital lymphoid infiltrates.

Harris NL, Pilch BZ, Bhan AK, Harmon DC, Goodman ML.

Am J Surg Pathol. 1984 Feb;8(2):83-91.

PMID:
6367504
19.

Atypical idiopathic orbital inflammation in a young girl.

Spindle J, Narang S, Purewal B, Shinder R.

Ophthal Plast Reconstr Surg. 2013 May-Jun;29(3):e86-8. doi: 10.1097/IOP.0b013e318275b649.

PMID:
23247034
20.

Orbital lymphoproliferative tumors: analysis of clinical features and systemic involvement in 160 cases.

Demirci H, Shields CL, Karatza EC, Shields JA.

Ophthalmology. 2008 Sep;115(9):1626-31, 1631.e1-3. doi: 10.1016/j.ophtha.2008.02.004. Epub 2008 Apr 28.

PMID:
18440641

Supplemental Content

Support Center